Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study

被引:13
|
作者
Abhyankar, Atul [1 ]
Abizaid, Alexandre [2 ]
Chamie, Daniel [3 ]
Rathod, Mihir [1 ]
机构
[1] Shree BD Mehta Mahavir Heart Inst, Dept Cardiol, Surat, Gujarat, India
[2] Univ Sao Paulo, Intervent Cardiol Dept, Sao Paulo, Brazil
[3] Dante Pazzanese Inst Cardiol, Invas Cardiol Dept, Sao Paulo, Brazil
关键词
coronary artery disease; drug-eluting stent; everolimus; percutaneous coronary intervention; sirolimus; PERCUTANEOUS CORONARY INTERVENTION; VASCULAR-RESPONSE; STRUT THICKNESS; THROMBOSIS; ANGIOGRAPHY; MECHANISMS; PATHOLOGY; IMPACT; RISK;
D O I
10.1002/ccd.28833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim The TAXCO study was designed to compare the degree of neointimal coverage and the prevalence of malapposition at 6 months subsequent to implantation of ultrathin biodegradable polymer-coated sirolimus-eluting stents (SES) and durable polymer-coated everolimus-eluting stents (EES) of thin strut thickness using optical coherence tomography (OCT). Methods The TAXCO study included a total of 42 patients who gave consent and underwent OCT examination between August 2017 and September 2017. Of 42, five patients' OCT examinations were of insufficient quality for quantitative analysis. Thus, the OCT analysis group consisted of 37 patients. Among them, 16 patients were treated with Xience (Abbott Vascular) and 21 with Tetriflex (Sahajanand Medical Technologies Pvt. Ltd., Surat, India), 6 (+/- 1) months earlier at our institution. The OCT was performed using a C7 Dragonfly (TM) imaging catheter (St. Jude Medical Inc.). All OCT images were analyzed at an independent core laboratory (Cardiovascular Research Center, Sao Paulo, Brazil) by analysts who were blinded to patient and procedural information. Results A total of 763 crosssections (6,882 struts) were analyzed in Xience group, and 1,127 crosssections (9,968 struts) in Tetriflex group. At 6 months, on per-lesion basis, no significant differences were observed between Xience group and Tetriflex group in mean percentage of uncovered struts (1.87 +/- 3.86 vs. 2.42 +/- 3.46, p = .137) and malapposed struts (0.05 +/- 0.2 vs. 0.21 +/- 0.69, p = .302). Strut-level neointimal thickness also did not differ between Xience group and Tetriflex group (0.18 +/- 0.12 vs. 0.14 +/- 0.08 mm, p = .286). Conclusion This OCT study found no significant difference in strut coverage and neointimal thickness at 6 months after implantation of biodegradable polymer-coated Tetriflex, when compared with durable polymer-coated Xience.
引用
收藏
页码:423 / 430
页数:8
相关论文
共 50 条
  • [21] Endothelial Barrier Protein Expression in Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Metallic Stents
    Mori, Hiroyoshi
    Cheng, Qi
    Lutter, Christoph
    Smith, Samantha
    Guo, Liang
    Kutyna, Matthew
    Torii, Sho
    Harari, Emanuel
    Acampado, Eduardo
    Joner, Michael
    Kolodgie, Frank D.
    Virmani, Renu
    Finn, Aloke V.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (23) : 2375 - +
  • [22] Long-term clinical, angiographic, and intravascular ultrasound outcomes of biodegradable polymer-coated sirolimus-eluting stents
    Han, Yaling
    Jing, Quanmin
    Chen, Xuezhi
    Wang, Shouli
    Ma, Yingyan
    Liu, Haiwei
    Luan, Bo
    Wang, Geng
    Li, Yi
    Wang, Zulu
    Wang, Dongmei
    Xu, Bo
    Gao, Runlin
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2008, 72 (02) : 177 - 183
  • [23] Clinical outcomes of ultrathin strut biodegradable polymer-coated everolimus-eluting stent in patients with coronary artery disease
    Patted, Suresh, V
    Thakkar, Ashok S.
    ARYA ATHEROSCLEROSIS, 2020, 16 (03) : 130 - 135
  • [24] Bioresorbable polymer-coated thin strut sirolimus-eluting stent vs durable polymer-coated everolimus-eluting stent in daily clinical practice: Propensity matched one-year results from interventional cardiology network registry
    Gasior, Pawel
    Gierlotka, Marek
    Szczurek-Katanski, Krzysztof
    Osuch, Marcin
    Gnot, Roman
    Hawranek, Michal
    Gasior, Mariusz
    Polonski, Lech
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (07) : E362 - E368
  • [25] A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study
    Han, Yaling
    Liu, Haiwei
    Yang, Yuejin
    Zhang, Jian
    Xu, Kai
    Fu, Guosheng
    Su, Xi
    Jiang, Tiemin
    Pang, Wenyue
    Chen, Jiyan
    Yuan, Zuyi
    Li, Hui
    Wang, Haichang
    Hong, Tao
    Liu, Huiliang
    Sun, Fucheng
    Allocco, Dominic J.
    Zhang, Mingdong
    Dawkins, Keith D.
    EUROINTERVENTION, 2017, 13 (10) : 1210 - 1217
  • [26] Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography
    Matsumoto, Daisuke
    Shite, Junya
    Shinke, Toshiro
    Otake, Hiromasa
    Tanino, Yusuke
    Ogasawara, Daisuke
    Sawada, Takahiro
    Paredes, Oscar Luis
    Hirata, Ken-ichi
    Yokoyama, Mitsuhiro
    EUROPEAN HEART JOURNAL, 2007, 28 (08) : 961 - 967
  • [27] Which is Better, Biodegradable polymer Coated Biolimus A9-eluting Stents or Biocompatible Durable-polymer Coated Everolimus-eluting Stents?: Serial Optical Coherence Tomographic Evaluation
    Shutta, Ryu
    Nishino, Masami
    Yasumoto, Koji
    Yasumura, Keisuke
    Yorifuji, Hiroki
    Masuyama, Kiyoshi
    Nushiro, Yu
    Kato, Taishi
    Idemoto, Akiko
    Tanaka, Akihiro
    Okamoto, Naotaka
    Mori, Naoki
    Yoshimura, Takahiro
    Makino, Nobuhiko
    Egami, Yasuyuki
    Tanouchi, Jun
    CIRCULATION, 2014, 130
  • [28] Vascular Healing After Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Stents in Chronic Total Occlusions
    Wang, Geng
    Li, Yi
    Lu, Wen
    Xu, Yawei
    Su, Xi
    Chen, Shaoliang
    Li, Yang
    Han, Yaling
    ARGET CTOOCT substudy Investigators
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2025, : 1124 - 1133
  • [29] Long-Term Follow-up of Neointimal Coverage of Sirolimus-Eluting Stents - Evaluation With Optical Coherence Tomography -
    Ishigami, Ken-ichi
    Uemura, Shiro
    Morikawa, Yoshinobu
    Soeda, Tsunenari
    Okayama, Satoshi
    Nishida, Taku
    Takemoto, Yasuhiro
    Onoue, Kenji
    Somekawa, Satoshi
    Takeda, Yukiji
    Kawata, Hiroyuki
    Horii, Manabu
    Saito, Yoshihiko
    CIRCULATION JOURNAL, 2009, 73 (12) : 2300 - 2307
  • [30] Comparison of Neointimal Coverage of Sirolimus-Eluting Stents and Paclitaxel-Eluting Stents Using Optical Coherence Tomography at 9 Months After Implantation
    Kim, Jin-Sun
    Kim, Jung-Sun
    Kim, Tae Hoon
    Fan, Chunyu
    Lee, Jung Myung
    Kim, Woong
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    CIRCULATION JOURNAL, 2010, 74 (02) : 320 - 326